Sign In
Buy FAMDF
$0.0090
-0.0004 (-4.66%)
At Close: Jun 03, 2026
Futura Medical ED drug roll continues apace
02:47am, Thursday, 19'th Oct 2023
The roll-out of Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s breakthrough erectile dysfunction gel continues apace with sales starting in the company's first market in the Middle East. Eroxon will now b
Futura Medical shares up on patent news - interesting at these levels, says bank
03:57am, Monday, 02'nd Oct 2023
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in sexual health products, has witnessed a 3% increase in its share price after securing a pivotal patent from the Europe
Futura Medical secures patent protection for ED gel out to 2040
02:34am, Monday, 02'nd Oct 2023
Futura Medical PLC (AIM:FUM, OTC:FAMDF), the drug developer specialising in sexual health products, has secured a significant win with the European Patent Office granting protection for MED3000, its e
Futura Medical CEO James Barder discusses FDA approval, market share gains, and plans for Eroxon
09:39am, Friday, 22'nd Sep 2023
In an exclusive with Proactive, James Barder, CEO of Futura Medical PLC (AIM:FUM, OTC:FAMDF), discusses the company's remarkable first half of the year, marked by FDA approval for its erectile dysfunc
Futura Medical: Pieces of the jigsaw falling into place, says investment bank
09:22am, Monday, 18'th Sep 2023
The past year has seen the pieces of the puzzle fall neatly into place for UK-based Futura Medical PLC (AIM:FUM, OTC:FAMDF), according to boutique investment bank, Liberum. The company has successfull
Futura Medical targets profitability as it sees early commercial traction for ED gel
02:52am, Monday, 18'th Sep 2023
Futura Medical PLC said it expects to be in a break-even position next year as the commercial traction grows around its erectile dysfunction gel Eroxon. The product, which has regulatory sign-off in
